| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Department of Foods and Nutrition, University of Georgia, Athens (MAJ, NAH, WRB, and JGF); the Centers for Disease Control and Prevention, Atlanta (EWG); and the Department of Medicine, University of Colorado Health Sciences Center, Denver (RHA and SPS).
Background: The effect of the folate food fortification program on the prevalence of hyperhomocysteinemia in the older population with coexisting vitamin B-12 deficiency is not known.
Objective: The objective was to determine the prevalence of hyperhomocysteinemia and vitamin B-12 deficiency in elderly who were using Title IIIc nutrition services, after folate food fortification in the United States.
Design: Demographic, nutritional, cognitive, routine diagnostic, and serum methylmalonic acid (MMA) and total homocysteine (tHcy) tests were performed in a convenience sample of 103 elderly enrolled in nutrition service programs in rural northeast Georgia. A subgroup (n = 27) was treated with vitamin B-12, 2.5 mg, and a multivitamin with 400 µg folic acid, 2 mg vitamin B-6, and 27 mg ferrous fumarate.
Results: The total cohort included 103 participants (
± SD age: 76.4 ± 8.1; 80% female; 68% white, 32% African American). Vitamin B-12 deficiency (serum vitamin B-12 < 258 pmol/L and MMA > 271 nmol/L) was present in 23%. Mean serum folate was high, 39.3 nmol/L, and no subject had serum folate < 6.8 nmol/L. Mean tHcy was 17.6 ± 7.2 µmol/L in vitamin B-12–deficient subjects and 10.8 ± 3.6 µmol/L in those who were nondeficient. Determinants of high tHcy were vitamin B-12 deficiency, high serum creatinine, and low red blood cell folate. Those with vitamin B-12 deficiency were more likely to have poor cognition (58% compared with 20%, P < 0.001) and anemia (38% compared with 18%, P = 0.042). High-dose oral B-12 therapy lowered mean MMA and tHcy by 49% and 32%, respectively.
Conclusion: Vitamin B-12 deficiency was prevalent and was associated with poor cognition, anemia, and hyperhomocysteinemia.
Key Words: Vitamin B-12 • folate • pepsinogen I • cognition • elderly • homocysteine • methylmalonic acid • anemia
This article has been cited by other articles:
|
|
 |
|
  M. C. Pflipsen, R. C. Oh, A. Saguil, D. A. Seehusen, and R. Topolski The Prevalence of Vitamin B12 Deficiency in Patients with Type 2 Diabetes: A Cross-Sectional Study J Am Board Fam Med, September 1, 2009; 22(5): 528 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hoey, J. Strain, and H. McNulty Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1981S - 1996S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ganji and M. R. Kafai Demographic, Lifestyle, and Health Characteristics and Serum B Vitamin Status Are Determinants of Plasma Total Homocysteine Concentration in the Post-Folic Acid Fortification Period, 1999-2004 J. Nutr., February 1, 2009; 139(2): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. McCracken, P. Hudson, R. Ellis, A. McCaddon, and the Medical Research Council Cognitive Function an Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P Stabler, R. H Allen, E. T Dolce, and M. A. Johnson Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1422 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Solomon Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing Blood, February 1, 2005; 105(3): 978 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. McLean, P. F. Jacques, J. Selhub, K. L. Tucker, E. J. Samelson, K. E. Broe, M. T. Hannan, L. A. Cupples, and D. P. Kiel Homocysteine as a Predictive Factor for Hip Fracture in Older Persons N. Engl. J. Med., May 13, 2004; 350(20): 2042 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Obeid, H. Schorr, R. Eckert, and W. Herrmann Vitamin B12 Status in the Elderly as Judged by Available Biochemical Markers Clin. Chem., January 1, 2004; 50(1): 238 - 241. [Full Text] [PDF]
|
|
|
|
|
|
S. P Stabler Vitamins, homocysteine, and cognition Am. J. Clinical Nutrition, September 1, 2003; 78(3): 359 - 360. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Carmel, R. Green, D. S. Rosenblatt, and D. Watkins Update on Cobalamin, Folate, and Homocysteine Hematology, January 1, 2003; 2003(1): 62 - 81. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
